CoChat

Investigation of charge ratio variation in mRNA – DEAE-dextran polyplex delivery systems

Open access
Siewert, C., Haas, H., Nawroth, T., Ziller, A., Nogueira, S.S., Schroer, M.A., Blanchet, C.E., Svergun, D.I., Radulescu, A., Bates, F., Huesemann, Y., Radsak, M.P., Sahin, U., Langguth, P. · 2019 · Biomaterials
Cited by 63

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

mRNA pharmaceuticals represent a new class of therapeutics, with applications, in cancer vaccination, tumour therapy and protein substitution. Formulations are required to deliver messenger RNA (mRNA) to the target sites where induction of genetic transfection following receptor mediated cell uptake & translation is required. In the current study, the cationic polysaccharide diethylaminoethylen (DEAE) - Dextran was selected as a model system carrier for the investigation of polyplex nanoparticle formation together with mRNA as a function of the molar ratio of the components. The structure of the mRNA/Dextran colloids was investigated as a function of the polymer-to-mRNA ratio and correlated with the biological activity determined by cellular transfection with luciferase coding mRNA. Dynamic light scattering (DLS), small angle x-ray scattering (SAXS), and small angle neutron scattering (SANS) with deuterium contrast variation were used to achieve structural insight into the systems. Similarly to previously investigated lipid based systems, colloidally stable particles with confined size were obtained with either excess of positive or negative charge. Highest activity was obtained with positive charge excess. From the scattering experiments information on the internal organization inside the polymer/mRNA systems was derived. Indication for the presence of structural elements in the length scale of ten to 20 nm were found in the excess of dextran, which could be due to either excess or particulate polymer. Information on the molecular organization of the mRNA nanoparticle products may provide a valuable basis for defining critical quality attributes of drug products for pharmaceutical application.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2018.10.020

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 63

Metadata

Authors
Siewert, C., Haas, H., Nawroth, T., Ziller, A., Nogueira, S. S., Schroer, M. A., Blanchet, C. E., Svergun, D. I., Radulescu, A., Bates, F., Huesemann, Y., Radsak, M. P., Sahin, U., & Langguth, P.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2019-02
Volume
192
Pages
612-620
ISSN
0142-9612 (ISSN-L)
OpenAlex
W2900720441
Cited by
63
References
8
FWCI
1.88
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigation of charge ratio variation in mRNA – DEAE-dextran polyplex delivery systems. https://app.cochat.ai/papers/10.1016/j.biomaterials.2018.10.020
The paper
Siewert, C., Haas, H., Nawroth, T., Ziller, A., Nogueira, S. S., Schroer, M. A., Blanchet, C. E., Svergun, D. I., Radulescu, A., Bates, F., Huesemann, Y., Radsak, M. P., Sahin, U., & Langguth, P. (2019). Investigation of charge ratio variation in mRNA – DEAE-dextran polyplex delivery systems. Biomaterials. https://doi.org/10.1016/j.biomaterials.2018.10.020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.